Should I open or buy a My Eyelab franchise in 2027?
Direct Answer
Yes for an operator who wants a tech-enabled, value-optical franchise — My Eyelab offers an affordable eyewear-and-eye-care model with telehealth-assisted exams and recession-resilient vision demand at moderate capital, backed by an established optical group. My Eyelab, part of the Now Optics group (sister brand to Stanton Optical), franchises value-optical retail centers offering affordable eyeglasses, contacts, and eye exams (often via telehealth/remote-doctor technology), targeting value-conscious consumers with same-day eyewear.
The 2026 FDD lists a franchise fee around $30,000-$50,000, total Item 7 investment of roughly $400,000 to $700,000, a royalty near 6%-8%, and a marketing fee. Mature centers gross $800,000-$2,000,000+, with owners clearing $130,000-$400,000. Its appeal is a value-optical positioning, telehealth-enabled exams (no on-site OD needed in some models), recession-resilient vision demand, an established optical group, and high-margin eyewear; the challenges are telehealth/regulatory considerations, optical competition, and staffing.
The Real Numbers
A My Eyelab operates as a value-optical center (3,000-4,500 sq ft) with an eyewear showroom and telehealth-assisted exam capability (remote-doctor technology where permitted), providing affordable glasses, contacts, and exams, backed by Now Optics' systems and supply chain.
| Line Item | Low | High | Notes |
|---|---|---|---|
| Franchise fee | $30,000 | $50,000 | Per 2026 FDD |
| Buildout / leasehold | $180,000 | $380,000 | Value-optical fit-out |
| Equipment & telehealth | $90,000 | $200,000 | Exam tech, optical lab, fixtures |
| Signage & decor | $20,000 | $60,000 | Brand image |
| Initial inventory (eyewear) | $40,000 | $110,000 | Frames, lenses, contacts |
| Initial marketing | $25,000 | $60,000 | Customer acquisition |
| Training & travel | $12,000 | $32,000 | Operator + staff |
| Working capital | $40,000 | $100,000 | Ramp |
| Total Item 7 | ~$400,000 | ~$700,000 | Per 2026 FDD |
| Royalty | ~6%-8% of gross | ||
| Marketing fee | ~2%-3% of gross |
Revenue reality: mature centers gross $800K-$2.0M+ with owners clearing $130K-$400K. My Eyelab's edge is its value-optical positioning (affordable eyewear and exams — capturing value-conscious consumers), telehealth-enabled exams (remote-doctor technology allows exams without a full-time on-site OD in some models — an operational/cost advantage, where regulations permit), recession-resilient vision demand (eyewear is largely necessary), an established optical group (Now Optics), and high-margin eyewear.
The trade-offs are telehealth/regulatory considerations (telehealth-optometry rules vary by state — a key diligence item), optical competition (Warby Parker, Costco, Lenscrafters, online), and staffing. Operators who leverage the value positioning and telehealth efficiency, navigate regulations, and drive eyewear sales perform best.
The telehealth model can lower the OD-staffing burden where permitted.
Who Wins With This Business
- Capital required: $400K-$700K, with $150,000-$250,000 liquid.
- Time commitment: full-time value-optical operation.
- Skills: value retail, eyewear sales, and telehealth/regulatory navigation.
- Geographic fit: value-conscious markets (telehealth-permitting states).
- Lifestyle fit: retail-and-tech-minded operator.
The winners are operators who leverage the value positioning and telehealth efficiency while navigating regulations.
Who Loses With This Business
- Operators who can't navigate telehealth-optometry regulations.
- Those who can't compete with value/online eyewear.
- Owners who can't drive eyewear sales.
- Buyers in states restricting telehealth optometry without a plan.
- Those who can't staff opticians.
2027 Market Conditions
- Demand: value eyewear and vision care are recession-resilient and value-driven.
- Telehealth: remote-exam technology is an operational advantage (where permitted).
- Established group: Now Optics systems and supply chain.
- High-margin eyewear: value + margin.
- Competition: Warby Parker, Costco, Lenscrafters, online eyewear.
The 90-Day Decision Tree
- Day 1-20: Read the 2026 FDD, Item 19, and telehealth-optometry regulations for your state (a key diligence item).
- Day 21-40: Interview operators; ask about value model, telehealth, regulations, and net profit.
- Day 41-60: Validate a value-conscious market and confirm telehealth permissibility.
- Day 61-100: Build, staff, and set up telehealth/exam capability.
- Day 101-130: Open and drive customer acquisition.
- Leverage the value positioning and telehealth efficiency.
- Drive eyewear sales (high-margin).
Alternative Plays
- Stanton Optical — value optical (Now Optics sister, see fr0966).
- My Eyelab for tech-enabled value optical.
- Pearle Vision — recognized eye care (see fr0964).
- Lenscrafters / optical — eyewear retail (EssilorLuxottica).
- Independent value-optical center — full control, no brand.
- Other optical/healthcare-retail franchises — adjacent models.
FAQ
How does the telehealth exam model work?
Remote-doctor technology lets a licensed optometrist conduct exams remotely (where state regulations permit). My Eyelab uses telehealth/remote-exam technology where an OD examines patients remotely via connected equipment, allowing exams without a full-time on-site OD in some models — an operational and cost advantage.
Critically, telehealth-optometry regulations vary by state (some restrict or prohibit it), so confirming permissibility in your state is a key diligence item. Where permitted, the telehealth model lowers the OD-staffing burden and supports the value positioning.
How much does a My Eyelab owner make?
Owners typically clear $130,000-$400,000 per center, on $800K-$2.0M+ revenue, driven by value-eyewear volume, high margins, and (where permitted) telehealth efficiency. Profitability depends on eyewear sales, the value positioning, and regulatory navigation. Operators who leverage value and telehealth efficiency and drive eyewear earn the most.
Review Item 19 — the value model and high-margin eyewear support strong revenue in receptive markets.
What's the value-optical advantage?
Affordable eyewear and exams capture value-conscious consumers — a large, recession-resilient market. My Eyelab targets value-conscious customers with affordable glasses, contacts, and exams (often same-day), capturing a large segment that prioritizes price. Vision care is largely necessary (recession-resilient), and the value positioning broadens the addressable market.
Combined with high-margin eyewear and telehealth efficiency, the value model drives strong volume and revenue — appealing to price-sensitive consumers, especially in tougher economies.
What's the biggest regulatory consideration?
Telehealth-optometry rules vary by state — confirm permissibility before investing. Some states restrict or prohibit telehealth/remote eye exams, which is central to My Eyelab's lower-cost model in some configurations. Confirm your state's telehealth-optometry regulations as a key diligence step — they determine whether the telehealth-efficient model is viable in your market.
Where telehealth is permitted, the model works well; where restricted, you'll need an on-site OD relationship (raising costs). Regulatory navigation is essential.
What is the biggest challenge?
Telehealth/regulatory navigation and optical competition. You must navigate telehealth-optometry regulations (varying by state — central to the model) and compete against Warby Parker, Costco, Lenscrafters, and online eyewear. Staffing and customer acquisition also matter.
Success requires confirming telehealth permissibility, leveraging the value positioning, driving eyewear sales, and competing on value/convenience. The recession-resilient demand and value positioning help, but regulatory navigation and competition are the key challenges.
Bottom Line
Open a My Eyelab if you want a tech-enabled, value-optical franchise with affordable eyewear, telehealth-assisted exams (where permitted), recession-resilient vision demand, an established optical group (Now Optics), and high-margin eyewear, you can navigate telehealth-optometry regulations, and you're in a value-conscious market. Its value positioning, telehealth efficiency, recession-resilient demand, and high-margin eyewear are genuine strengths.
Skip it if your state restricts telehealth optometry without a plan, you can't compete with value/online eyewear, or you can't drive eyewear sales. Confirm telehealth regulations and validate Item 19. For retail-and-tech-minded operators who leverage value and telehealth in receptive markets, My Eyelab offers a value-optical path — the value positioning, telehealth/regulatory navigation, and eyewear sales are the keys.
Sources
- My Eyelab Franchise Disclosure Document (2026 filing) — Items 5, 6, 7, 19, 20
- My Eyelab / Now Optics official franchise site — investment range and value-optical model
- Entrepreneur Franchise listings — My Eyelab
- IBISWorld — Optical Retail & Eye-Care Services in the US, 2026 industry report
- Statista — US value-eyewear and vision-care market, 2025-2026
- Telehealth-optometry regulatory data by state, 2025-2026
- Vision Council — eyewear and vision-care demand data 2026
- International Franchise Association (IFA) — 2027 Franchise Economic Outlook
- Franchise Business Review — optical-franchise satisfaction data
- US Census — vision-care-spending and demographic data, 2025-2026